Tetrahydrofuran

Tetrahydrofuran

SCHEMBL1011787

C1CCOC1.[AlH3].[HH].[LiH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111979757-B Method for modifying asphalt-based carbon fiber surface by using rigid-flexible phase-coordination polymer system 陕西科技大学 2022-11-29 CN claimed
CN-112921658-A Asphalt-based carbon fiber composite material and preparation method thereof 天津大迈科技有限公司 2021-06-08 CN claimed
CN-111979757-A Method for modifying surface of asphalt-based carbon fiber by using rigid-flexible phase-complementary polymer system 陕西科技大学 2020-11-24 CN claimed
CN-1621397-A Process and apparatus for automatically synthesizing carbon-11-methyl iodide ZHANG JINMING (CN) 2005-06-01 CN claimed
CN-118005611-A Probes for imaging huntingtin CHDI基金会股份有限公司 2024-05-10 CN disclosed
CN-117916245-A Pyrimidine ring compound and preparation method and application thereof 劲方医药科技(上海)有限公司 2024-04-19 CN disclosed
CN-117897382-A Nitrogen-containing tricyclic compounds and pharmaceutical uses thereof 日本烟草产业株式会社 2024-04-16 CN disclosed
US-11890288-B2 Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2024-02-06 US disclosed
CN-107074817-B Probes for imaging huntingtin CHDI基金会股份有限公司 2023-12-15 CN disclosed
US-20230364105-A1 SULFONAMIDE OR SULFINAMIDE COMPOUND HAVING EFFECT OF INDUCING BRD4 PROTEIN DEGRADATION AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-11-16 US disclosed
CN-111655692-B Nitrogen-containing heterocyclic amide compound and medical application thereof 日本烟草产业株式会社 2023-10-10 CN disclosed
US-20230295202-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2023-09-21 US disclosed
US-4886794-A ANTIHISTAMINES, ANTIALLERGENS A. H. ROBINS COMPANY, INCORPORATED (US) 1989-12-12 US disclosed
EP-0291244-A1 Cyclic carbamate derivatives A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) (US) 1988-11-17 EP disclosed
CN-88100911-A Antihypercholesterolemic tetrazolium compounds 1988-09-28 CN disclosed
US-RE31617-E ANTICOAGULANTS; HYPOTENSIVE AND BRONCHODILATOR AGENTS BRISTOL-MYERS COMPANY (US) 1984-06-26 US disclosed
US-4111850-A CHARGE TRANSFER COMPLEX OF A FLUORENONE AND A CARBAZOLE AMP INCORPORATED (US) 1978-09-05 US disclosed
US-4061778-A HYPOLIPIDEMIC SANDOZ, INC. (US) 1977-12-06 US disclosed
US-4011344-A HYPOLIPIDEMIC AGENTS SANDOZ, INC. (US) 1977-03-08 US disclosed
US-3932407-A BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTICOAGULANTS BRISTOL-MYERS COMPANY (US) 1976-01-13 US disclosed